We report a fatal case of drug toxicity associated with torsade de pointes following an overdose of the tetracyclic antidepressant, maprotiline (Ludiomil). Tissue and plasma levels were obtained at autopsy and are noted. In addition, the cardiovascular effects, pharmacokinetics, and toxicity of maprotiline are reviewed and compared with that of tricyclic antidepressants.
MaitreLStaehleinMBeinHJ. Blockade of noradrenalin uptake by 34276-Ba, a new antidepressant drug. Biochem Pharmacol1971; 20: 2169–86.
2.
BaltzerVDelina-StulaABeinHJ. Richerche pharmacologiche sulla maprotilina muova sostanza ad azione antidepressiva. Bull Chim Pharm1973; 112: 611–9.
3.
AngstJFreiMLehmannMA double-blind comparative study on the effectiveness of maprotiline (Ludiomil) and imipramine (Tofranil) in endogenous depression. In: KielholzP. ed. Depressive illness. Diagnosis, assessment, and treatment. Berne: Huber, 1972: 245–52.
4.
LauritsenB. Continental hospital studies with maprotiline (Ludiomil). J Int Med Res1975; 3 (suppl 2): 61–6.
5.
WellsBGGelanburgAJ. Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochloride. Pharmacotherapy1981; 1: 121–39.
DessertenneF. La tachycardie ventriculaire a'deux foyers opposes variable. Arch Mal Coeur1966; 59: 263–72.
8.
PoklisAWellsCEJuengeEC. Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulforides. J Anal Toxicol1982; 6: 250–2.
9.
FowlerNOMcCallDChouTe-ChuanElectrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol1976; 37: 223–30.
10.
KemperAJDunlapRPietroDA. Thioridazine-induced torsade de pointes. JAMA1983; 249: 2931–4.
11.
RaederEAZinsliMBurckhardtD. Effect of maprotiline on cardiac arrhythmias. Br Med J1979; 2: 102.
12.
BrunnerHHedwallPRMeierMCardiovascular effects of preparation CIBA 34, 276-Ba and imipramine. Agents Actions1971; 2: 69–82.
13.
AydF. Maprotiline: An effective tetracyclic antidepressant. Int Drug Ther Newslett1973; 8: 17–24.
14.
HarperBHughesIE. Comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline, and mianserin in relation to their ability to block noradrenalin uptake. J Pharmacol1977; 59: 651–60.
15.
BurckhardtDRaederEMullerVCardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA1978; 239: 213–6.
16.
TobiasJMAronowWS. Cardiotoxicity of amitriptyline and doxepin. Clin Pharmacol Ther1981; 29: 359–64.
17.
TobiasJMAronowWS. Effect of amitriptyline antidotes on repetitive extrasystole threshold. Clin Pharmacol Ther1980; 27: 602–6.
18.
SmithWMGallagherJJ. Les torsades de pointes: An unusual ventricular arrhythmia. Ann Intern Med1980; 93: 578–84.
19.
StrasbergBCoelhoAWelchWDoxepin induced torsade de pointes. Pace1982; 109: 873–7.
20.
HerrmannHEKaplanLMBieresBE. Q-T prolongation and torsades de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotiline. Am J Cardiol1983; 51: 904–6.
21.
KriklerDMCurryPUL. Torsades de pointes, an atypical ventricular tachycardia. Br Heart J1976; 38: 117–20.
22.
RasmussenJ. Amitriptyline and imipramine poisoning. Lancet1965; 2: 850–1.
23.
ElonenELimoilaMLukhariIConcentration of tricyclic antidepressants in plasma, heart and skeletal muscle after their intravenous infusion to anaesthetized rabbits. Acta Pharmacol Toxicol1975; 37: 274–81.
24.
HurstHEJarboeCH. Clinical finding, elimination pharmacokinetics, and tissue drug concentrations following a fatal amitriptyline intoxication. Clin Toxicol1981; 18: 119–25.
25.
AlkalayDWagnerWWCarlsenSBioavailability and kinetics of maprotiline. Clin Pharmacol Ther1980; 27: 697–703.
26.
LuscombeDKJonesRBBeaumontGPlasma concentrations of maprotiline in man (abstract). Presented at VI World Congress of Psychiatry, Honolulu, Hawaii, Sept. 3, 1977.
27.
ReissWFunggeldEWImhofPThe pharmacokinetic properties of maprotiline (Ludiomil) in man. J Int Med Res1975; 3 (suppl 2): 16–41.
28.
JonesRDLuscombeDK. Single-dose study with maprotiline in normal subjects. Presented at Ludiomil Symposium, Malta, Nov., 1976.
29.
BraithwaiteRA. Plasma protein binding of tricyclic antidepressants. Postgrad Med J1980; 56 (suppl 1): 107–11.
30.
MulgirigamaLDPareCMDTurnerPClinical response in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response. Postgrad Med J1977; 53 (suppl 4): 155–9.
31.
AngstJRothweilerR. Blood levels and clinical effects of maprotiline. Symposia Medica Hoechst 8, Stuttegart: F.V. Schattauer Verlag, 1974.
32.
SzelessSKleinbergerGKotzaurekRFatal self-poisoning with the tetracyclic antidepressive drug Ludiomil. Wien Klin Wochenschr1975; 87: 254–8.
33.
PinderRMBrodgenRNSpeightTMMaprotiline: A review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs1977; 13: 321–52.
34.
TonnesenECrawfordM. Maprotiline (Ludiomil) poisoning. A severe case with permanent cerebral damage. Ugeskr Laeger1980; 142: 1290–1.
35.
JukesAM. Maprotiline (Ludiomil): Side effects and overdosage. J Int Med Res1975; 3 (suppl 2): 126–31.
36.
ParkJProudfootAT. Acute poisoning with maprotiline hydrochloride. Br Med J1977; 1: 1573.
37.
CromePNewmanB. The problem of tricyclic antidepressant poisoning. Postgrad Med J1979; 55: 528–32.
38.
ShepherdGAAKerrF. Maprotiline hydrochloride and grandmal seizures. Br Med J1978; 1: 1523.
39.
MarksPAndersenJVincentREpileptiform seizures with maprotiline hydrochloride. Postgrad Med J1979; 55: 742.
40.
MeekDBottMHMamtoraHConvulsions following maprotiline overdose (letter). Br Med J1975; 2: 275.
41.
LutierFLefelevreJPStephanE. Acute intoxication due to Ludiomil. Arch Med Normandie1977; 22: 539–46.
42.
CromePNewmanB. Poisoning with maprotiline and mianserin (letter). Br Med J1977; 2: 260.
